Number of items: 1.
Using machine learning (ML) and explainable artificial intelligence (AI) to accurately predict immune-checkpoint inhibitor (ICI) response in small cell (SCLC) and non-small cell (NSCLC) lung cancer patients. (2025)
L. Sharma,
V. Balaji,
A. Katumba,
E. Mohan,
I. Mporas,
D. Alrifai,
J. Chow,
T. Sevitt,
K. Nathan,
R. Shah,
J.S.C. Waters
and
S. Adeleke
This list was generated on Sun Aug 23 01:50:52 2026 BST.